GNI Group Ltd. (2160.T)

JPY 3460.0

(2.37%)

Inventory Summary of GNI Group Ltd.

  • GNI Group Ltd.'s latest annual inventory in 2023 was 2.33 Billion JPY , up 37.63% from previous year.
  • GNI Group Ltd.'s latest quarterly inventory in 2024 Q2 was 2.97 Billion JPY , up 19.21% from previous quarter.
  • GNI Group Ltd. reported annual inventory of 1.69 Billion JPY in 2022, up 22.47% from previous year.
  • GNI Group Ltd. reported annual inventory of 1.38 Billion JPY in 2021, up 47.91% from previous year.
  • GNI Group Ltd. reported quarterly inventory of 2.97 Billion JPY for 2024 Q2, up 19.21% from previous quarter.
  • GNI Group Ltd. reported quarterly inventory of 1.7 Billion JPY for 2023 Q1, up 0.89% from previous quarter.

Annual Inventory Chart of GNI Group Ltd. (2023 - 2007)

Historical Annual Inventory of GNI Group Ltd. (2023 - 2007)

Year Inventory Inventory Growth
2023 2.33 Billion JPY 37.63%
2022 1.69 Billion JPY 22.47%
2021 1.38 Billion JPY 47.91%
2020 934.83 Million JPY 15.84%
2019 806.97 Million JPY 31.94%
2018 611.62 Million JPY -4.09%
2017 637.68 Million JPY 144.68%
2016 260.62 Million JPY 48.87%
2015 175.06 Million JPY -20.57%
2014 220.39 Million JPY 80.08%
2013 122.38 Million JPY 66.44%
2012 73.53 Million JPY 38.13%
2011 53.23 Million JPY 55.96%
2010 34.13 Million JPY 0.0%
2008 78.9 Million JPY -30.33%
2007 113.26 Million JPY 0.0%

Peer Inventory Comparison of GNI Group Ltd.

Name Inventory Inventory Difference
KOHJIN BIO CO LTD 683.01 Million JPY -241.228%
PRISM BioLab Co.,LTD 17.92 Million JPY -12899.175%
Linical Co., Ltd. - JPY -Infinity%
Trans Genic Inc. 2.22 Billion JPY -4.62%
MEDINET Co., Ltd. 67.48 Million JPY -3353.745%
Soiken Holdings Inc. 1.12 Billion JPY -107.93%
Cytori Cell Research Institute, Inc. 103.53 Million JPY -2151.069%
AnGes, Inc. 1.61 Billion JPY -44.239%
OncoTherapy Science, Inc. 73.99 Million JPY -3049.532%
Nxera Pharma Co., Ltd. 2.9 Billion JPY 19.717%
Immuno-Biological Laboratories Co., Ltd. 321.91 Million JPY -623.991%
NanoCarrier Co., Ltd. 184 Thousand JPY -1266542.391%
Carna Biosciences, Inc. 140.14 Million JPY -1563.067%
CanBas Co., Ltd. 728 Thousand JPY -320040.385%
D. Western Therapeutics Institute, Inc. 87.86 Million JPY -2552.564%
RaQualia Pharma Inc. 147.93 Million JPY -1475.394%
Chiome Bioscience Inc. 64.1 Million JPY -3535.519%
Kidswell Bio Corporation 875.65 Million JPY -166.158%
PeptiDream Inc. 2.4 Billion JPY 3.059%
Oncolys BioPharma Inc. 5.34 Million JPY -43528.267%
Ribomic Inc. 2.27 Million JPY -102389.974%
SanBio Company Limited - JPY -Infinity%
Healios K.K. - JPY -Infinity%
BrightPath Biotherapeutics Co., Ltd. 1.00 JPY -233062199900.0%
Kubota Pharmaceutical Holdings Co., Ltd. 36 Million JPY -6373.95%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM 29 Million JPY -7936.628%
CellSource Co., Ltd. 305.92 Million JPY -661.828%
FunPep Company Limited 25.54 Million JPY -9025.023%
Kringle Pharma, Inc. 364.05 Million JPY -540.182%
Stella Pharma Corporation 1.11 Billion JPY -108.789%
TMS Co., Ltd. 50.02 Million JPY -4558.915%
Noile-Immune Biotech Inc. 20.9 Million JPY -11050.768%
Cuorips Inc. 1.04 Million JPY -223353.691%
K Pharma,Inc. 10.79 Million JPY -21491.829%
Takara Bio Inc. 11.85 Billion JPY 80.332%
ReproCELL Incorporated 248.14 Million JPY -839.237%
PhoenixBio Co., Ltd. 450.58 Million JPY -417.241%
StemCell Institute Inc. 42.26 Million JPY -5414.699%
Japan Tissue Engineering Co., Ltd. 228.56 Million JPY -919.676%
CellSeed Inc. 46.19 Million JPY -4945.619%